Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-11-02 4:30 pm Purchase |
2023-10-23 | 13G | Viking Therapeutics, Inc. VKTX |
VIKING GLOBAL INVESTORS LP | 5,858,532 5.900% |
5,858,532 (New Position) |
Filing History |
| 2023-10-16 4:30 pm Sale |
2023-10-04 | 13D | Standard BioTools Inc. LAB |
VIKING GLOBAL INVESTORS LP | 8,289,116 9.500% |
-34,705 (-0.42%) |
Filing History |
| 2023-10-06 4:15 pm Purchase |
2023-09-26 | 13G | Five9, Inc. FIVN |
VIKING GLOBAL INVESTORS LP | 3,647,595 5.100% |
3,647,595 (New Position) |
Filing History |
| 2023-09-22 5:24 pm Unchanged |
2023-09-20 | 13D | Cazoo Group Ltd CZOO |
VIKING GLOBAL INVESTORS LP | 30,000 7.200% |
0 (Unchanged) |
Filing History |
| 2023-09-21 5:10 pm Purchase |
2023-09-19 | 13G | RayzeBio, Inc. Common Stock RYZB |
VIKING GLOBAL INVESTORS LP | 6,642,700 10.900% |
6,642,700 (New Position) |
Filing History |
| 2023-08-24 4:30 pm Purchase |
2023-08-14 | 13G | Valvoline Inc. VVV |
VIKING GLOBAL INVESTORS LP | 8,338,456 6.000% |
8,338,456 (New Position) |
Filing History |
| 2023-07-19 9:52 pm Sale |
2023-07-18 | 13D | BridgeBio Pharma, Inc. BBIO |
VIKING GLOBAL INVESTORS LP | 25,120,991 15.700% |
-1,500,000 (-5.63%) |
Filing History |
| 2023-06-26 5:05 pm Sale |
2023-06-22 | 13G | Roivant Sciences Ltd. ROIV |
VIKING GLOBAL INVESTORS LP | 75,238,700 9.900% |
-13,000,000 (-14.73%) |
Filing History |
| 2023-06-20 4:30 pm Purchase |
2023-06-07 | 13G | NewAmsterdam Pharma Company N.V. NAMS |
VIKING GLOBAL INVESTORS LP | 6,524,565 7.980% |
6,524,565 (New Position) |
Filing History |
| 2023-06-16 4:17 pm Unchanged |
2023-06-15 | 13D | Cazoo Group Ltd CZOO |
VIKING GLOBAL INVESTORS LP | 30,000 7.200% |
0 (Unchanged) |
Filing History |
| 2023-06-05 5:00 pm Purchase |
2023-05-26 | 13G | Verastem, Inc. VSTM |
VIKING GLOBAL INVESTORS LP | 1,320,656 7.900% |
1,320,656 (New Position) |
Filing History |
| 2023-05-16 5:27 pm Unchanged |
2023-05-12 | 13D | Cazoo Group Ltd CZOO |
VIKING GLOBAL INVESTORS LP | 30,000 7.200% |
0 (Unchanged) |
Filing History |
| 2023-04-27 4:30 pm Unchanged |
2023-04-25 | 13D | Cazoo Group Ltd CZOO |
VIKING GLOBAL INVESTORS LP | 30,000 7.200% |
0 (Unchanged) |
Filing History |
| 2023-03-21 4:46 pm Unchanged |
2023-03-17 | 13D | Cazoo Group Ltd CZOO |
VIKING GLOBAL INVESTORS LP | 30,000 7.200% |
0 (Unchanged) |
Filing History |
| 2023-02-27 5:10 pm Purchase |
2023-02-27 | 13D | Cazoo Group Ltd CZOO |
VIKING GLOBAL INVESTORS LP | 30,000 7.200% |
30,000 (New Position) |
Filing History |
| 2023-02-14 1:18 pm Purchase |
2022-12-31 | 13G | Pharvaris N.V. PHVS |
VIKING GLOBAL INVESTORS LP | 3,231,923 9.700% |
776,387 (+31.62%) |
Filing History |
| 2023-02-14 1:18 pm Sale |
2022-12-31 | 13G | Guardant Health, Inc. GH |
VIKING GLOBAL INVESTORS LP | 4,107,644 4.000% |
-1,014,851 (-19.81%) |
Filing History |
| 2023-02-14 1:18 pm Sale |
2022-12-31 | 13G | Amylyx Pharmaceuticals, Inc. AMLX |
VIKING GLOBAL INVESTORS LP | 4,634,606 7.000% |
-1,135,930 (-19.68%) |
Filing History |
| 2023-02-14 1:18 pm Purchase |
2022-12-31 | 13G | Trevi Therapeutics, Inc. TRVI |
VIKING GLOBAL INVESTORS LP | 6,162,362 9.990% |
177,628 (+2.97%) |
Filing History |
| 2023-02-14 1:18 pm Purchase |
2022-12-31 | 13G | Inhibrx Biosciences, Inc. INBX |
VIKING GLOBAL INVESTORS LP | 6,639,199 15.200% |
1,333,333 (+25.13%) |
Filing History |